Best Medical Device Development Companies

TTP vs Veranex: full comparison for 2026

Quick verdict

TTP (4.4/5) edges ahead of Veranex (4.2/5) overall. TTP is the better choice for pharma device programs, inhalers and injectors. Veranex is the stronger option for device design plus clinical trials and reimbursement. The right choice depends on your project size, budget, and required tech stack.

TTP vs Veranex: head-to-head summary

Criterion TTP Veranex
Founded 1987 2021
HQ Melbourn, Cambridgeshire, UK Raleigh, NC, USA
Team size Not published 800+
Rating 4.4 / 5 4.2 / 5
Primary differentiator Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients One contract can cover engineering, clinical studies, regulatory strategy and reimbursement
Pricing model Time and materials, phased fixed project Fixed project, time and materials
Min. engagement Not disclosed Not disclosed
Primary tech stack Ultrasound, Microfluidics, Embedded C/C++ ISO 13485 QMS, SolidWorks, Embedded C/C++
Industries served Drug delivery, Surgical & robotics, Diagnostics & lab devices Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery, Digital health

TTP vs Veranex: overview

TTP

TTP (The Technology Partnership) has operated for around 40 years from its own science park in Melbourn, South Cambridgeshire. In December 2021 TTP Group moved to 100% employee ownership through an Employee Ownership Trust. Its Medical Devices team works on drug delivery, surgical systems and diagnostics, and the wider company does deep technology work in sectors such as life science instruments and industrial products. Headcount is not published in a form we could verify.

Veranex

Veranex was formed in 2021 by Summit Partners, which combined Providence-based device developer Ximedica (founded 1985) with Quartesian and Boston Healthcare Associates. It has since acquired Experien Group, IMM Recherche, the healthcare design firm Worrell, Fusion Biotec and Horus Scientific. Headquartered in Raleigh, North Carolina, it reports more than 800 staff and offers product design and engineering, clinical research (CRO) services, regulatory work and market access consulting.

Services and capabilities: TTP vs Veranex

Capability TTP Veranex
Electronics & PCB design ✓ ✓
Firmware & embedded software ✓ ✗
SaMD & companion apps ✗ ✗
Connected devices & IoT ✗ ✗
Industrial design & human factors ✗ ✓
Mechanical engineering ✓ ✓
Device cybersecurity ✗ ✗
Regulatory & QMS support ✓ ✓
Manufacturing & scale-up ✗ ✗

Tech stack comparison: TTP vs Veranex

Framework / platform TTP Veranex
Embedded C/C++ ✓ ✓
Embedded Linux N/A N/A
RTOS N/A N/A
BLE N/A N/A
Cloud (AWS/Azure) N/A N/A
IEC 62304 N/A N/A
ISO 14971 N/A N/A
ISO 13485 QMS ✓ ✓
Qt N/A N/A

Pricing comparison: TTP vs Veranex

Criterion TTP Veranex
Minimum engagement Not disclosed Not disclosed
Engagement models Consulting, Fixed project, Time & materials Consulting, Fixed project, Time & materials
Rate transparency Not public Not public
Price tier Mid-market Mid-market

Target audience comparison: TTP vs Veranex

Dimension TTP Veranex
Best company size Startup to mid-market Startup to mid-market
Best industries Drug delivery, Surgical & robotics, Diagnostics & lab devices Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery
Best use cases Designing an autoinjector or inhaler for a pharma combination product, Developing a surgical energy device Startup that needs design, a clinical study and an FDA strategy from one partner, Human-centered redesign of a surgical instrument
Typical project type Consulting Consulting

TTP vs Veranex: pros and cons

TTP
+ Employee ownership since 2021 removes pressure from outside investors
+ Well regarded for drug delivery devices, an area where mechanics and human factors decide success
+ Own science park with lab and workshop space for physical prototyping
+ Specialist depth in ultrasound and fluidics
- Does not publish headcount or rates, which makes early budgeting harder
- UK-centric delivery; US clients work across time zones
- Pricing sits with the premium Cambridge consultancies
Veranex
+ Rare combination of engineering with CRO, regulatory and market access services
+ Ximedica brings decades of ISO 13485 device development experience
+ Worrell adds human-centered design for healthcare
+ Large enough to run several workstreams at once
- Built from many acquisitions since 2021, so teams and processes are still being joined up
- Private-equity ownership by Summit Partners
- Buyers who only need engineering may pay for a broader structure than they use

Who should choose TTP?

A typical fit: designing an autoinjector or inhaler for a pharma combination product.

Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Surgical & robotics, Diagnostics & lab devices.

Who should choose Veranex?

A typical fit: startup that needs design, a clinical study and an FDA strategy from one partner.

One contract can cover engineering, clinical studies, regulatory strategy and reimbursement. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery, Digital health.

Decision matrix: TTP vs Veranex

Your situation Recommended choice
You need full-ownership delivery on a defined project scope TTP
You need a large dedicated team for an ongoing programme Check each company's engagement model
Your budget is at the lower end Compare: TTP (Not disclosed) vs Veranex (Not disclosed)
You need specialist depth in a specific vertical Veranex
You need staff augmentation or team extension Neither; consider alternatives that offer staff aug
You need consulting before committing to a build Both may offer discovery engagements

Use case fit: TTP vs Veranex

Use case TTP fit Veranex fit Winner
Designing an autoinjector or inhaler for a pharma combination product Strong Limited TTP
Developing a surgical energy device Strong Limited TTP
Startup that needs design, a clinical study and an FDA strategy from one partner Limited Strong Veranex
Human-centered redesign of a surgical instrument Limited Strong Veranex

Verdict: TTP vs Veranex

TTP (4.4/5) is the stronger overall choice for most Medical Device Development projects. Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients.

Veranex (4.2/5) is worth a look if you need human-centered redesign of a surgical instrument. If your situation matches that, Veranex is a competitive option.

Related comparisons

TTP vs Veranex FAQ

Is TTP better than Veranex?

TTP (4.4/5) scores higher overall, but "better" depends on your use case. TTP's strongest advantage: employee ownership since 2021 removes pressure from outside investors. Veranex's strongest advantage: rare combination of engineering with CRO, regulatory and market access services.

How do TTP and Veranex differ in pricing?

TTP uses time and materials, phased fixed project pricing. Veranex uses fixed project, time and materials pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.

Which is better for enterprise: TTP or Veranex?

Veranex is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.

What are the main differences between TTP and Veranex?

TTP's primary differentiator is: employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Veranex's primary differentiator is: one contract can cover engineering, clinical studies, regulatory strategy and reimbursement. They also differ in team size (Not published vs 800+), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Drug delivery, Surgical & robotics vs Surgical & therapeutic devices, Diagnostics & lab devices).

Verify all details directly with each company before making a decision.